Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A. - Wikidata - wikimedia - TriplyDB

Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A.

Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A.

http://www.wikidata.org/entity/Q51050606

about

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease The Incremental Induction of Neuroprotective Properties by Multiple Therapeutic Strategies for Primary and Secondary Neural Injury Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.Gene expression profiling and association with prion-related lesions in the medulla oblongata of symptomatic natural scrapie animals.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy.Melatonin in Alzheimer's disease Does melatonin ameliorate neurological changes associated with Alzheimer's disease in ovariectomized rat model?Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Protein phosphorylation in neurodegeneration: friend or foe?Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression.Impaired Memory and Evidence of Histopathology in CA1 Pyramidal Neurons through Injection of Aβ1-42 Peptides into the Frontal Cortices of Rat.Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway.Chronic Melatonin Treatment Prevents Memory Impairment Induced by Chronic Sleep Deprivation.Melatonin attenuates isoflurane-induced acute memory impairments in aged rats.Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures.Citalopram attenuates tau hyperphosphorylation and spatial memory deficit induced by social isolation rearing in middle-aged rats.

P2860

Q24627125-42115F99-1562-40D2-AC10-0AF7DBCCB202 Q26795755-7A4D9CC0-2FC6-44C6-AFC1-860A7ED44297 Q26799870-C962E0DA-C547-4C92-A66D-420347DDB18C Q28537637-56D371CC-94E3-431B-A5D3-37868EF498A6 Q31134674-65A70813-EE51-4B7A-951E-004DDE7DFEDC Q33918266-AE02A1CC-9F9B-49ED-BD8D-3F746E93F70E Q34416921-90EDADA1-B43B-4411-9249-8C53C560ACFA Q35183471-18F14CDB-CBDB-43A9-ADE8-2BF8046F3F73 Q37091982-F95E06DA-B0C7-4BA8-956E-5085C025BCAC Q37199376-4189BEF1-569B-4BD9-ACE8-17095C89F329 Q38022179-488A5EB1-7024-4258-B94D-5D5388E36B46 Q38214594-5BF18D89-0A56-4C06-825D-45814398CE74 Q38253060-17CAF443-E26D-4E97-B13A-86BACC6F6D20 Q38834700-8B74B029-4FE9-40F0-BF1A-9BD3874E72B9 Q39129957-47C9AC23-75B8-4F7A-A3C3-C9CD4A58E96E Q41873106-6A68E240-CC57-44DF-8794-833E1C45E679 Q44478653-7AF7CCA7-6283-4DD3-A409-1C5FE98B4B6F Q46713691-3ADBD8D8-A2AD-4390-95A0-3097AC6F697B Q48013655-D1DE2CB8-48D2-4024-B7C7-F22C67C37630 Q48125798-29EC49D1-9B1E-4E17-ABE6-E1B9F43AAF06 Q48158214-C715C166-79E8-4A5E-8B35-780ACB1AE50D

P2860

Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A.

http://www.wikidata.org/entity/Q51050606

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@en

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@nl

type

label

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@en

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@nl

prefLabel

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@en

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@nl

P1433

Q51050606-70C73DA2-D62C-4BAF-B71E-1815A77D14E4

P1476

Q51050606-C2297B38-16AE-47FE-A8BD-0D2DF200B7D0

P2093

Q51050606-024B358D-C899-42EF-BD3F-135319756C35

Q51050606-156D2E79-C563-4E54-AECE-386C4983F6AF

Q51050606-1F6D5569-315D-4486-A7E3-C47BF32067BE

Q51050606-3EEF7FA7-302C-4BB0-98F8-EFEB0AF01B98

Q51050606-437C27EC-AB59-447E-A063-C0BD97E5469F

Q51050606-90955905-BB05-492C-8AF0-41FC5A015905

Q51050606-A9E0E1FB-04B4-4F49-8AFB-3F6A84C9D91A

Q51050606-CDB4BE4D-D149-4BC5-8511-DD37C72A48C2

Q51050606-E9E2FAFD-FAC1-4BD3-B690-0F426261AA73

P2860

Q51050606-1E53016D-5180-4A33-8AE5-C825B6ACAB06

Q51050606-274FC1EF-2F2F-4DC7-BDED-FE0BFC06A6DC

Q51050606-4025A3DB-B105-42C0-97F2-AE729C63D77C

Q51050606-4F5DC873-78FA-4A25-A01A-3F2D86DA5723

Q51050606-51ECD05B-B0A7-4B0F-BD8E-04579CF7D271

Q51050606-54091EFA-4BC1-4273-9931-3EB1A2D041C9

Q51050606-5C07510A-7E5B-4679-8BBF-180890EA0645

Q51050606-5EC9C707-611A-4307-A83C-C34E3815CBF4

Q51050606-646C0C1A-3FB5-44A4-9D28-066069F8DA04

Q51050606-70A10C3F-5682-407D-8C8A-8DDEE1BF2865

P304

Q51050606-40E10F1A-8762-49E8-B53F-8CDE6EBBD7C5

P31

Q51050606-28E2260B-2520-4645-93EB-A4870D1D9DBD

P356

Q51050606-474E397E-4400-4750-B451-FF514B63A0A4

P407

Q51050606-7B9D4E65-DCEA-455B-A7F1-230BBE72712E

P433

Q51050606-D5A8E9ED-907F-4914-803E-E4903C4607CF

P478

Q51050606-215516BF-093D-4087-891F-E0C2EBAA1630

P577

Q51050606-013EC436-7E8F-486F-BCE1-86AE7C202058

P698

Q51050606-FF46DD7C-5E82-43FA-B199-D88267629053

P921

Q51050606-7B3161BF-1165-43F3-85C5-6BD3D227886E

Q51050606-BD5F800F-B75A-48AB-B444-A07882FC46F8

P356

0269881110367723

P1433

Journal of Psychopharmacology

P1476

Melatonin ameliorates Alzheime ...... irment induced by calyculin A.

@en

P2093

Jing Feng

http://www.w3.org/2001/XMLSchema#string

Jinzhuo Luo

http://www.w3.org/2001/XMLSchema#string

Qing Tian

http://www.w3.org/2001/XMLSchema#string

Qiuyue Zhang

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

Xifei Yang

http://www.w3.org/2001/XMLSchema#string

Yin Li

http://www.w3.org/2001/XMLSchema#string

Ying Yang

http://www.w3.org/2001/XMLSchema#string

Zhengqi Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Tau pathology in Alzheimer disease and other tauopathies

Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training

Melatonin in humans

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.

Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.

Phosphoprotein phosphatase activities in Alzheimer disease brain.

Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells.

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

Neurofilament proteins in neurodegenerative diseases.

P304

1118-1125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881110367723

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20542922

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease